JOINDER TO STOCKHOLDERS’ AGREEMENTJoinder Agreement • June 26th, 2019 • Thomas H. Lee Advisors, LLC • Services-commercial physical & biological research
This Joinder Agreement (this “Joinder Agreement”) is made as of the date written below by the undersigned (the “Joining Party”) in accordance with the Stockholders’ Agreement dated as of May 10, 2017 (the “Stockholders’ Agreement”) by and among Syneos Health, Inc. (f/k/a INC Research Holdings, Inc.), Thomas H. Lee Equity Fund VI, L.P. and the other signatories that are party thereto as the same may be amended from time to time. Capitalized terms used, but not defined, herein shall have the meaning ascribed to such terms in the Stockholders’ Agreement.
JOINT FILING AGREEMENT PURSUANT TO RULE 13d-1(k)(1)Joint Filing Agreement • June 26th, 2019 • Thomas H. Lee Advisors, LLC • Services-commercial physical & biological research
In accordance with Rule 13d-1(k) under the Securities Exchange Act of 1934, as amended, the persons named below agree to the joint filing on behalf of each of them of the Schedule 13D to which this Agreement is an exhibit (and any further amendment filed by them) with respect to the shares of Class A Common Stock of Syneos Health, Inc. This agreement may be executed simultaneously in any number of counterparts, all of which together shall constitute one and the same instrument.
JOINDER TO STOCKHOLDERS’ AGREEMENTJoinder Agreement • June 26th, 2019 • Thomas H. Lee Advisors, LLC • Services-commercial physical & biological research
This Joinder Agreement (this “Joinder Agreement”) is made as of the date written below by the undersigned (the “Joining Party”) in accordance with the Stockholders’ Agreement dated as of May 10, 2017 (the “Stockholders’ Agreement”) by and among Syneos Health, Inc. (f/k/a INC Research Holdings, Inc.), Thomas H. Lee Equity Fund VI, L.P. and the other signatories that are party thereto as the same may be amended from time to time. Capitalized terms used, but not defined, herein shall have the meaning ascribed to such terms in the Stockholders’ Agreement.
